"Isolate Id","Study","Species","Organism Group","Country","State","Gender","Age Group","Speciality","Source","In / Out Patient","Year","Phenotype","MIC","breakpoint","Drug"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","4","Susceptible","Amikacin"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"2","Susceptible","Amikacin"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL",">32","Resistant","Amoxycillin clavulanate"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"16","Intermediate","Amoxycillin clavulanate"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","4","Susceptible","Ampicillin"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,">32","Resistant","Ampicillin"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","<=0.12","Susceptible","Cefepime"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"<=0.12","Susceptible","Cefepime"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","0.06","Susceptible","Ceftazidime"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"0.06","Susceptible","Ceftazidime"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","<=0.06","Susceptible","Ceftriaxone"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"<=0.06","Susceptible","Ceftriaxone"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","2","Intermediate","Imipenem"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"1","Susceptible","Imipenem"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","0.25","Susceptible","Levofloxacin"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"0.5","Susceptible","Levofloxacin"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","0.25","Susceptible","Meropenem"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"0.06","Susceptible","Meropenem"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","0.5","Susceptible","Piperacillin tazobactam"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"0.5","Susceptible","Piperacillin tazobactam"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","1","Susceptible","Tigecycline"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"2","Susceptible","Tigecycline"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","<=0.015","Susceptible","Aztreonam"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"<=0.015","Susceptible","Aztreonam"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","0.06","Susceptible","Ceftaroline"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"0.06","Susceptible","Ceftaroline"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","0.06","Susceptible","Ceftazidime avibactam"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"0.03","Susceptible","Ceftazidime avibactam"
"1414151","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,"Female","19 to 64 Years","Surgery General","GU: Urine","Inpatient","2016","non ESBL","0.25","Susceptible","Doripenem"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"0.12","Susceptible","Doripenem"
"1577329","Inform","Providencia alcalifaciens","Enterobacteriaceae","Argentina",NA,NA,"Unknown","Medicine General","GU: Prostate","Inpatient","2017",NA,"0.12","Susceptible","Ceftolozane tazobactam"
